# Association of visual acuity with sleep quality and sleep duration in patients with type 2 diabetes: evidence from a cross-sectional analysis of the Fushun Diabetic Retinopathy Study

**Authors:** Yu Wang, Shisong Rong, Zixi Zhou, Yuanbo Liang, Zhong Lin, Fenghua Wang, Qitong Wang, Kemi Feng, Xiaoxia Ding, Dongxiao Zang, Dong Li, Bo Zang

PMC · DOI: 10.3389/fpsyt.2025.1521347 · Frontiers in Psychiatry · 2025-07-17

## TL;DR

This study finds that worse visual acuity in type 2 diabetes patients is linked to poorer sleep quality, but not sleep duration.

## Contribution

The novel finding is a J-shaped relationship between visual acuity and sleep quality, even with mild vision changes.

## Key findings

- A J-shaped association was found between visual acuity and sleep quality (P for non-linearity = 0.004).
- Higher odds of poor sleep quality were observed in groups with worse visual acuity compared to optimal VA.
- No significant association was found between visual acuity and sleep duration.

## Abstract

To examine the association between visual acuity (VA), sleep quality, and sleep duration among Chinese adults.

Data were derived from the Fushun Diabetic Retinopathy Cohort Study (FS-DIRECT), a cross-sectional, community-based study conducted in Fushun, China, from July 2012 to May 2013. The study included 1284 participants (58.7% female, mean age 61.3 years) with type 2 diabetes. VA was assessed using the LogMAR chart and stratified into six groups based on LogMAR scores: <0 (optimal), 0-0.1, 0.1-0.2, 0.2-0.3, 0.3-0.5, and ≥0.5 for multivariable-adjusted analyses. Sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI).

Restricted cubic splines revealed a significant J-shaped association between VA and sleep quality (P for non-linearity = 0.004). This relationship was characterized by a positive correlation for VA values below 0.5 LogMAR, with the association plateauing at higher VA levels. Compared to the optimal VA group, the odds ratios (ORs) for poor sleep quality were: 1.18 (95% CI: 1.05-1.33) for 0-0.1, 1.73 (1.52-1.97) for 0.1-0.2, 1.99 (1.74-2.28) for 0.2-0.3, 1.55 (1.33-1.80) for 0.3-0.5, and 1.80 (1.54-2.10) for ≥0.5. No significant association was found between VA and sleep duration, whether short or long, in fully adjusted models.

Our findings reveal a J-shaped association between visual acuity and sleep quality, while no significant association was observed with sleep duration. Even mild vision changes, not typically classified as impairment, may significantly affect sleep. This underscores the importance of early sleep health consideration in eye care.

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, OPN4 (opsin 4) [NCBI Gene 94233] {aka MOP}
- **Diseases:** REM sleep disorders (MESH:D020187), DIRECT (MESH:D051556), Chronic sleep disturbances (MESH:D012893), Sleep deprivation (MESH:D012892), obstructive sleep apnea (MESH:D020181), reduced vision (MESH:D015354), retinal damage (MESH:D012164), cardiovascular diseases (MESH:D002318), hyperlipidemia (MESH:D006949), optic nerve disorders (MESH:D000080344), glaucoma (MESH:D005901), depression (MESH:D003866), cataract (MESH:D002386), CHD (MESH:D003327), cognitive impairments (MESH:D003072), optic disc disorders (MESH:D009901), stroke (MESH:D020521), DM (MESH:D003920), NPDR (OMIM:603933), VA (MESH:D014786), AMD (MESH:D008268), insomnia (MESH:D007319), inflammatory (MESH:D007249), metabolic disorders (MESH:D008659), daytime dysfunction (MESH:D006970), CKD (MESH:D051436), DR (MESH:D003930), ocular diseases (MESH:D005128), T2DM (MESH:D003924)
- **Chemicals:** melatonin (MESH:D008550), alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12310673/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12310673/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12310673/full.md

---
Source: https://tomesphere.com/paper/PMC12310673